These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7589901

  • 21. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM, Klein RC, Oka M, Cowan KH.
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [Abstract] [Full Text] [Related]

  • 22. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
    Kamano H, Tanaka T, Ohnishi H, Kubota Y, Ikeda K, Takahara J, Irino S, Ottalenghi S.
    Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
    [Abstract] [Full Text] [Related]

  • 23. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
    Bartůnek P, Králová J, Blendinger G, Dvorák M, Zenke M.
    Oncogene; 2003 Apr 03; 22(13):1927-35. PubMed ID: 12673198
    [Abstract] [Full Text] [Related]

  • 24. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
    Yen A, Samuel V, Forbes M.
    J Cell Physiol; 1992 Oct 03; 153(1):147-56. PubMed ID: 1522128
    [Abstract] [Full Text] [Related]

  • 25. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors.
    Wessely O, Deiner EM, Beug H, von Lindern M.
    EMBO J; 1997 Jan 15; 16(2):267-80. PubMed ID: 9029148
    [Abstract] [Full Text] [Related]

  • 26. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
    Bies J, Hoffman B, Amanullah A, Giese T, Wolff L.
    Oncogene; 1996 Jan 18; 12(2):355-63. PubMed ID: 8570212
    [Abstract] [Full Text] [Related]

  • 27. Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
    Choe KS, Radparvar F, Matushansky I, Rekhtman N, Han X, Skoultchi AI.
    Cancer Res; 2003 Oct 01; 63(19):6363-9. PubMed ID: 14559825
    [Abstract] [Full Text] [Related]

  • 28. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
    Yamada T, Kihara-Negishi F, Yamamoto H, Yamamoto M, Hashimoto Y, Oikawa T.
    Exp Cell Res; 1998 Nov 25; 245(1):186-94. PubMed ID: 9828115
    [Abstract] [Full Text] [Related]

  • 29. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J, Meneceur P, Ray D, Moreau-Gachelin F.
    Cancer Res; 1988 Jul 15; 48(14):3972-6. PubMed ID: 3164254
    [Abstract] [Full Text] [Related]

  • 30. c-Myb function in fibroblasts.
    Bein K, Husain M, Ware JA, Mucenski ML, Rosenberg RD, Simons M.
    J Cell Physiol; 1997 Dec 15; 173(3):319-26. PubMed ID: 9369944
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of erythro-myeloid differentiation by constitutive expression of a DNA binding-deficient c-myb mutant: implication for c-myb function.
    Sala A, Bellon T, Melotti P, Peschle C, Calabretta B.
    Blood; 1995 Nov 01; 86(9):3404-12. PubMed ID: 7579444
    [Abstract] [Full Text] [Related]

  • 32. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP, Holmes KL, Morse HC, Thorgeirsson SS.
    Exp Cell Res; 1988 Oct 01; 178(2):185-98. PubMed ID: 2458948
    [Abstract] [Full Text] [Related]

  • 33. C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cells.
    Poindessous-Jazat V, Augery-Bourget Y, Robert-Lézénès J.
    Leukemia; 2002 Feb 01; 16(2):233-43. PubMed ID: 11840290
    [Abstract] [Full Text] [Related]

  • 34. NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity.
    Francastel C, Poindessous-Jazat V, Augery-Bourget Y, Robert-Lézénès J.
    Leukemia; 1997 Feb 01; 11(2):273-80. PubMed ID: 9009092
    [Abstract] [Full Text] [Related]

  • 35. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation.
    Francastel C, Mazouzi Z, Robert-Lézénès J.
    Leukemia; 1992 Sep 01; 6(9):935-9. PubMed ID: 1518304
    [Abstract] [Full Text] [Related]

  • 36. Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb.
    Melotti P, Calabretta B.
    Blood; 1996 Mar 15; 87(6):2221-34. PubMed ID: 8630382
    [Abstract] [Full Text] [Related]

  • 37. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.
    Yamada T, Kondoh N, Matsumoto M, Yoshida M, Maekawa A, Oikawa T.
    Blood; 1997 Feb 15; 89(4):1383-93. PubMed ID: 9028962
    [Abstract] [Full Text] [Related]

  • 38. Only the DNA binding and transactivation domains of c-Myb are required to block terminal differentiation of murine erythroleukemia cells.
    Cuddihy AE, Brents LA, Aziz N, Bender TP, Kuehl WM.
    Mol Cell Biol; 1993 Jun 15; 13(6):3505-13. PubMed ID: 8497265
    [Abstract] [Full Text] [Related]

  • 39. Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA.
    Weber BL, Westin EH, Clarke MF.
    Science; 1990 Sep 14; 249(4974):1291-3. PubMed ID: 2205003
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.